Clinical utility of MCM2 and CD44 expression in clear cell renal cell carcinoma

Clinical utility of MCM2 and CD44 expression in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) has an unpredictable clinical consequence even with the use of usual prognostic factors. To determine whether utilization of cell proliferation and cell adhesion by using MCM2 and CD44 immuno-expression could predict the biological performance of ccRCC. MCM2 a...

Full description

Bibliographic Details
Main Authors:	Mariana F. Gayyed, Medhat M. Soliman, Maram El-Hussieny
Format:	Article
Language:	English
Published:	Termedia Publishing House 2021-02-01
Series:	Polish Journal of Pathology
Subjects:	ccrcc mcm2 cd44 immunohistochemistry prognosis.
Online Access:	https://www.termedia.pl/Clinical-utility-of-MCM2-and-CD44-expression-in-clear-cell-renal-cell-carcinoma,55,43322,1,1.html

Similar Items

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
by: Jing Ma, et al.
Published: (2020-03-01)

Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: An immunohistochemical study
by: Pournima Y Godge, et al.
Published: (2011-01-01)

Prognostic significance of CD44s expression in resected non-small cell lung cancer
by: Ko Yoon, et al.
Published: (2011-08-01)

CD44 Is Associated with Poor Prognosis of ccRCC and Facilitates ccRCC Cell Migration and Invasion through HAS1/MMP9
by: Tan Du, et al.
Published: (2023-07-01)

Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C<sub>44</sub>Mab-108 for Immunohistochemistry
by: Hiroyuki Suzuki, et al.
Published: (2023-02-01)

A Novel Anti-CD44 Variant 3 Monoclonal Antibody C<sub>44</sub>Mab-6 Was Established for Multiple Applications
by: Hiroyuki Suzuki, et al.
Published: (2023-05-01)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
by: Si D, et al.
Published: (2020-02-01)

Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C<sub>44</sub>Mab-3 for Multiple Applications against Pancreatic Carcinomas
by: Yuma Kudo, et al.
Published: (2023-04-01)

CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies
by: Min Fang, et al.
Published: (2016-11-01)

Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C<sub>44</sub>Mab-18 for Immunohistochemical Analysis against Oral Squamous Cell Carcinomas
by: Kenichiro Ishikawa, et al.
Published: (2023-06-01)

Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C44Mab-5
by: Shinji Yamada, et al.
Published: (2018-07-01)

A study on the expression of CD44 adhesion molecule in oral squamous cell carcinoma and its correlation with tumor histological grading
by: Srilalitha Kaza, et al.
Published: (2018-01-01)

CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma
by: Pouyan Amini Shakib, et al.
Published: (2015-01-01)

Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance
by: Walter Henriques da Costa, et al.
Published: (2012-08-01)

Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C<sub>44</sub>Mab-34, for Multiple Applications against Oral Carcinomas
by: Hiroyuki Suzuki, et al.
Published: (2023-04-01)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
by: Lucía Montero-Montero, et al.
Published: (2020-09-01)

Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
by: Magdalena Chrabańska, et al.
Published: (2023-02-01)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
by: Yong Ching-Shya, et al.
Published: (2012-07-01)

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
by: Can Chen, et al.
Published: (2024-02-01)

CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study
by: Unedo Hence Markus Sihombing, et al.
Published: (2022-10-01)

Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
by: Susu Han, et al.
Published: (2019-02-01)

The Role of CD44 in Disease Pathophysiology And Targeted Treatment
by: Andre R. Jordan, et al.
Published: (2015-04-01)

AURKB: a promising biomarker in clear cell renal cell carcinoma
by: Bangbei Wan, et al.
Published: (2019-09-01)

Differential expression of HIF-1α in CD44<sup>+</sup>CD24<sup>-/low </sup>breast ductal carcinomas
by: Soares Fernando A, et al.
Published: (2011-08-01)

Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma
by: Gun Banu, et al.
Published: (2012-07-01)

Immunohistochemical Study of the CD44 Expression in Benign, Borderline and Malignant Surface Epithelial Ovarian Tumors and Metastatic Ovarian Tumors
by: Gamze Yurdakan, et al.
Published: (2007-12-01)

CD44 Expression in Papillary Thyroid Carcinoma and its Correlation with Prognostic Factors
by: Fatemeh Baghertash, et al.
Published: (2023-08-01)

Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
by: Fan Zhang, et al.
Published: (2022-09-01)

A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
by: Zuhu Yu, et al.
Published: (2023-03-01)

Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma
by: Zhang F, et al.
Published: (2022-11-01)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
by: Mahdi Abdoli Shadbad, et al.
Published: (2021-08-01)

Metabolic reprogramming of clear cell renal cell carcinoma
by: Haiyan Zhu, et al.
Published: (2023-06-01)

KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma
by: Ke-Hao Pan, et al.
Published: (2023-09-01)

Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
by: Ingrīda Čēma, et al.
Published: (2021-11-01)

Single-Cell Sequencing to Identify Six Heat Shock Protein (HSP) Genes-Mediated Progression Subtypes of Clear Cell Renal Cell Carcinoma
by: Li Q, et al.
Published: (2021-07-01)

CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia
by: Luísa Vieira Codeço Marques, et al.
Published: (2018-10-01)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
by: Youlong Huili, et al.
Published: (2022-08-01)

Expression of CD44 in Tumor Tissue and Serum of Small Cell Lung Cancer and Its Clinical Prognostic Significance
by: Ying WANG, et al.
Published: (2021-08-01)

Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma
by: Yuxiong Jiang, et al.
Published: (2022-04-01)

Basic Characteristics and Survival Outcomes of Asian-American Patients with Clear Cell Renal Cell Carcinoma and Comparisons with White Patients: A Population-Based Analysis
by: Li X, et al.
Published: (2021-11-01)